Project Grant S10OD034295

Award Date 4/1/23
Completion Date 3/31/25
Dollars Obligated $240K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award of $449,228 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund the development of an integrated system for long-term electrophysiological profiling of human brain organoids. The key products and services to be delivered include: A biological assay chamber that supports chronic electrophysiology while maintaining the health of brain organoids. High-fidelity, 3D neural probes for chronic,...
This Project Grant award of $517,546, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to optimize, benchmark, and validate a novel multimodal microelectrode array (MEA) probe that integrates fast-scan cyclic voltammetry (FSCV) for sub-second neuromodulator sensing with parallel electrical recording. The research team, led by investigators from Dartmouth College, aims to develop this integrated MEA platform...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), provides $237,914 to The Johns Hopkins University to develop and evaluate a novel approach for implanting high-density microelectrode arrays to spatially resolve single-unit neuronal activities from nonlinearly organized brain structures and circuits. The key objectives are to: 1) develop an implantation apparatus and optimize the probe design using an in-vitro test...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, awarded the University of Oregon a $301,172 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The purpose of this 3-year project is to develop scalable fabrication methods for high-density amorphous silicon carbide microelectrode arrays to enable chronic neural interfacing for recording neural activity in studies...
This Project Grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will fund the development of advanced tools for genetically targeted all-optical electrophysiology in behaving mice. Specifically, the $4,381,836 award to President and Fellows of Harvard College, doing business as Harvard University, will support efforts to co-develop two-photon excitable genetically encoded voltage indicators and a new type of two-photon voltage-imaging...
This NSF Engineering Program award of $605,320 to North Carolina State University (NC State) supports the development of a flexible, FMRI-compatible neural probe with multi-modal sensing and modulation capabilities. The novel probe is designed to advance understanding of neural circuit dynamics and enable closed-loop neuromodulation for treating neurological disorders. Key product elements include: Flexible, multi-shank neural probe fabricated using polymeric materials to enable deep brain...
This $566,015 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), supports the University of Utah's development of a configurable and thermo-responsive intracortical electrode array platform using 3D printing and gallium-based liquid metal electrode materials. The goal is to create a next-generation implantable neural...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $343,203 to Cyion Technologies LLC to develop a novel in vitro electrophysiology system for high-throughput measurement of intracellular action potential (IAP) in human-derived cardiomyocytes. The system leverages a 3D nanoelectrode array (NEA) technology to enable scalable recordings of IAP signals from many individual cardiomyocytes. This...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $3,045,502 Project Grant to the Regents of the University of Michigan on August 18, 2022 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The grant funds the development of optical neural motes to enable high-density neural recording through intact dura in nonhuman primates. Specifically, the University of Michigan will design...
The National Institute of Mental Health (NIMH) has awarded a $992,826 Project Grant (R44MH135529) to Blackrock Microsystems, Inc. to develop the "OA2" - a high-density chronic optogenetic interface for primate brain research. The goal of this Small Business Innovation Research (SBIR) Phase I project is to engineer a new two-level optogenetic stimulation device that combines Blackrock's "Utah Optrode Array" technology with a surface-level stimulation array. This will enable...

HIGH-DENSITY MICROELECTRODE ARRAY - PI: KIEHL, THOMAS R. , REGENERATIVE RESEARCH FOUNDATION, HIGH-DENSITY MICROELECTRODE ARRAY SUMMARY/ABSTRACT WITH THIS APPLICATION, WE REQUEST FUNDING TO PROCURE THE HYPERCAM ALPHA PLATFORM FROM 3BRAIN AG (ZURICH SWITZERLAND). THE HYPERCAM ALPHA IS A MULTI-WELL, HIGH-DENSITY MICROELECTRODE ARRAY SYSTEM FOR OBSERVING AND STIMULATING IN VITRO ELECTROPHYSIOLOGICAL ACTIVITY IN ELECTRO-ACTIVE CELL CULTURES, CELL CONSTRUCTS, ORGANOIDS, AND PRIMARY TISSUE SAMPLES. THIS INSTRUMENT PROVIDES SEVERAL KEY FEATURES: 1) HIGH-RESOLUTION RECORDING CAPABILITY; 2) DYNAMIC STIMULATION FUNCTIONALITY, 3) A MULTI-WELL FORMAT; 4) 3D SENSOR OPTIONS, AND 5) SOPHISTICATED ANALYSIS SOFTWARE. THESE FEATURES ENSURE ITS UTILITY ACROSS A RANGE OF BIOLOGICAL INVESTIGATIONS TO MEET THE HIGH-THROUGHPUT AND HIGH-FIDELITY DEMANDS OF OUR USERS AND COLLABORATORS. THIS SUBMISSION ADDRESSES A SIGNIFICANT UNMET NEED IN OUR INSTITUTE AND REGION, NAMELY THE ABILITY TO TEST THE FUNCTIONAL IMPACT OF CELLULAR INTERACTIONS, GENETIC CHANGES OR OF PERTURBAGENS ON NEURAL SYSTEMS AT SCALE. THE RESEARCHERS IDENTIFIED IN THIS SUBMISSION (SPANNING FIVE INSTITUTIONS) ARE ENGAGED IN THE STUDY OF A WIDE RANGE OF NEUROLOGICAL DISFUNCTION FROM DISEASE, AGING, INJURY AND DEVELOPMENTAL DISORDERS. PLACEMENT OF THIS INSTRUMENT WILL DIRECTLY ADVANCE WORK IN FRONTOTEMPORAL DEMENTIA, ALZHEIMER'S, VASCULAR CONTRIBUTIONS TO DEMENTIA, SEX- SPECIFIC AGING IMPACT ON COGNITIVE FUNCTION, TISSUE REGENERATION, SPINAL CORD INJURY, BRAIN DEVELOPMENT, AND DISEASE IMPACT ON NEUROLOGICAL DEVELOPMENT. THIS INSTRUMENT WILL HELP TO QUANTIFY MODEL SYSTEMS, SUCH AS BRAIN ORGANOIDS, THAT HAVE FAST BECOME THE WORKHORSES OF THE FIELD. PROJECTS DESCRIBED HERE ALSO ADVANCE THE DEVELOPMENT OF NEW, MORE CAPABLE, MODEL SYSTEMS AND EVEN OF NEXT GENERATION MEA-RELATED DEVICES. THE PRIMARY, CONCRETE, LONG-RANGE BENEFIT OF THIS INSTRUMENT TO THE BIOMEDICAL RESEARCH GOALS OF RRF/NSCI/NEURACELL IS TO PROVIDE ROUTINE, CLEAR, HIGH-RESOLUTION, EASILY CAPTURED, CHARACTERIZATION AND QUANTIFICATION OF THE BEHAVIOR AND FUNCTION OF THE NUMEROUS NEUROLOGICAL SYSTEMS UNDER STUDY AT OUR INSTITUTION. THE USE OF THIS INSTRUMENT WILL BE INTEGRATED INTO NEARLY EVERY RESEARCH PROGRAM WITHIN OUR WALLS. BEYOND OUR ORGANIZATION, THIS INSTRUMENT WILL: AMPLIFY THE EXISTING PROGRAMS OF OUR MAJOR USERS; HELP OUR MINOR USERS ESTABLISH AND GROW THEIR RELATED RESEARCH PROGRAMS; AND ENDOW A FOUNDATION FOR FUTURE TECHNOLOGY DEVELOPMENT.

Posted 3/17/23